Neurocrine Biosciences
NBIX
Reported
Wednesday, October 30
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 1.51 | 1.81 | 0.30 | 19.87% |
| Revenue | 601M | 622M | - | - |
WhatIF - Earnings
EPS Beat Expectations by $0.30
Neurocrine Biosciences (NBIX:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything